Evaluation of Ipsilateral Tubal Patency After Conservative Medical or Surgical Treatment. (EENCBE)
Ectopic Pregnancy
About this trial
This is an interventional treatment trial for Ectopic Pregnancy focused on measuring uncomplicated ectopic pregnancy methotrexate
Eligibility Criteria
Inclusion Criteria:
Patient presenting with Ectopic Pregnancy, associated with quantitative titers of βHCG ≥ 100 mUI / ml, without intrauterine gestational sac.
Patient presenting uncomplicated Ectopic Pregnancy with an adnexal mass diameter ≤4 cm diagnosed by abdominal and / or transvaginal ultrasonography.
Absence of heartbeat. No toxicity to MTX. Normal laboratory tests (blood count, coagulogram, liver and kidney function). Hemodynamic stability.
Exclusion Criteria:
- Complicated Ectopic Pregnancy.
- Ectopic pregnancy is out of the tuba on ultrasound
- Patients with Immunosuppression.
- Allergy to MTX.
- Patients with Active Respiratory Disease, Blood Dyspasia, Peptic Ulcer, Renal Insufficiency and Hepatic Insufficiency.
- Do not accept to participate in the study.
Sites / Locations
- Maria Dolores Reguera SaboridoRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Medical treatment
Surgical treatment
By administering a single intramuscular dose of 50mg / m2 / Sc of Methotrexate.
Will be performed by laparoscopy or laparotomy, using the Linear Salpingostomy technique.